Immune modulators as adjuncts for the prevention and treatment of invasive fungal infections

Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis

(2012) Joseph N. Jarvis et al.   AIDS

Nonspecific Effect of Mycograb on Amphotericin B MIC

(2012) D. L. Richie et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Recent progress in vaccines against fungal diseases

(2012) Antonio Cassone et al.   CURRENT OPINION IN MICROBIOLOGY

Cross-protective TH1 immunity against Aspergillus fumigatus and Candida albicans

(2011) C. Stuehler et al.   BLOOD

How I treat mucormycosis

(2011) D. P. Kontoyiannis et al.   BLOOD

Vaccine and Monoclonal Antibody That Enhance Mouse Resistance to Candidiasis

(2011) Hong Xin et al.   Clinical and Vaccine Immunology

Immunotherapy of Cryptococcus infections

(2011) C. Antachopoulos et al.   CLINICAL MICROBIOLOGY AND INFECTION

A highly immunogenic recombinant and truncated protein of the secreted aspartic proteases family (rSap2t) ofCandida albicansas a mucosal anticandidal vaccine

(2011) Silvia Sandini et al.   FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY

Study of immunological aspects of aspergillosis in mice and effect of polyene macrolide antibiotic (SJA-95) and IFN-γ: A possible role of IFN-γ as an adjunct in antifungal therapy

(2011) Suresh R. Naik et al.   IMMUNOLOGY LETTERS

CD4+T Cells Mediate the Protective Effect of the Recombinant Asp f3-Based Anti-Aspergillosis Vaccine

(2011) Diana Diaz-Arevalo et al.   INFECTION AND IMMUNITY

Vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 cells in mice

(2011) Marcel Wüthrich et al.   JOURNAL OF CLINICAL INVESTIGATION

Human NK Cells Display Important Antifungal Activity against Aspergillus fumigatus, Which Is Directly Mediated by IFN-  Release

(2011) M. Bouzani et al.   JOURNAL OF IMMUNOLOGY

Toward Developing a Universal Treatment for Fungal Disease Using Radioimmunotherapy Targeting Common Fungal Antigens

(2011) R. A. Bryan et al.   MYCOPATHOLOGIA

Active and Passive Immunization with rHyr1p-N Protects Mice against Hematogenously Disseminated Candidiasis

(2011) Guanpingsheng Luo et al.   PLoS One

Immunisation with the glycolytic enzyme enolase confers effective protection against Candida albicans infection in mice

(2011) Wen qing Li et al.   VACCINE

Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America

(2010) John R. Perfect et al.   CLINICAL INFECTIOUS DISEASES

Candida albicansHyr1p Confers Resistance to Neutrophil Killing and Is a Potential Vaccine Target

(2010) Guanpingsheng Luo et al.   JOURNAL OF INFECTIOUS DISEASES

Radioimmunotherapy Is More Effective than Antifungal Treatment in Experimental Cryptococcal Infection

(2010) Ruth A. Bryan et al.   JOURNAL OF INFECTIOUS DISEASES

Human Natural Killer Cells Exhibit Direct Activity Against Aspergillus fumigatus Hyphae, But Not Against Resting Conidia

(2010) Stanislaw Schmidt et al.   JOURNAL OF INFECTIOUS DISEASES

Vertebral osteomyelitis due toAspergillus fumigatusin a patient with chronic granulomatous disease successfully treated with antifungal agents and interferon-gamma

(2010) Jaffar A. Al-Tawfiq et al.   MEDICAL MYCOLOGY

Developing a vaccine against aspergillosis

(2010) David A. Stevens et al.   MEDICAL MYCOLOGY

Beta-glucan-CRM197 conjugates as candidates antifungal vaccines

(2010) Carla Bromuro et al.   VACCINE

Production of Extracellular Traps against Aspergillus fumigatus In Vitro and in Infected Lung Tissue Is Dependent on Invading Neutrophils and Influenced by Hydrophobin RodA

(2010) Sandra Bruns et al.   PLoS Pathogens

Independent Association between Rate of Clearance of Infection and Clinical Outcome of HIV‐Associated Cryptococcal Meningitis: Analysis of a Combined Cohort of 262 Patients

(2009) Tihana Bicanic et al.   CLINICAL INFECTIOUS DISEASES

The role of neutrophils in the development and outcome of zygomycosis in haematological patients

(2009) L. Pagano et al.   CLINICAL MICROBIOLOGY AND INFECTION

Anti-Aspergillushuman host defence relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity

(2009) Louis Y. A. Chai et al.   IMMUNOLOGY

Early NK Cell-Derived IFN-  Is Essential to Host Defense in Neutropenic Invasive Aspergillosis

(2009) S. J. Park et al.   JOURNAL OF IMMUNOLOGY

Immune Sensing of Aspergillus fumigatus Proteins, Glycolipids, and Polysaccharides and the Impact on Th Immunity and Vaccination

(2009) S. Bozza et al.   JOURNAL OF IMMUNOLOGY

Protection by Anti-β-Glucan Antibodies Is Associated with Restricted β-1,3 Glucan Binding Specificity and Inhibition of Fungal Growth and Adherence

(2009) Antonella Torosantucci et al.   PLoS One

Th1-Th17 Cells Mediate Protective Adaptive Immunity against Staphylococcus aureus and Candida albicans Infection in Mice

(2009) Lin Lin et al.   PLoS Pathogens

Randomized phase III study of granulocyte transfusions in neutropenic patients

(2008) M G Seidel et al.   BONE MARROW TRANSPLANTATION

Clinical-scale generation of human anti-Aspergillus T cells for adoptive immunotherapy

(2008) L Tramsen et al.   BONE MARROW TRANSPLANTATION

Therapeutic Efficacy of a Conjugate Vaccine Containing a Peptide Mimotope of Cryptococcal Capsular Polysaccharide Glucuronoxylomannan

(2008) K. Datta et al.   Clinical and Vaccine Immunology

Efungumab and caspofungin: pre-clinical data supporting synergy

(2008) S. Hodgetts et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Fungal infections in hematopoietic stem cell transplant recipients

(2008) Kieren A. Marr   MEDICAL MYCOLOGY

Synthetic glycopeptide vaccines combining  -mannan and peptide epitopes induce protection against candidiasis

(2008) H. Xin et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Interleukin-15 increases Paracoccidioides brasiliensis killing by human neutrophils

(2007) Elisandra Garcia Tavian et al.   CYTOKINE